The effect of oral iron with or without multiple micronutrients on hemoglobin concentration and hemoglobin response among nonpregnant Cambodian women of reproductive age: a 2 x 2 factorial, double-blind, randomized controlled supplementation trial
Crystal D Karakochuk, Mikaela K Barker, Kyly C Whitfield, Susan I Barr, Suzanne M Vercauteren, Angela M Devlin, Jennifer A Hutcheon, Lisa A Houghton, Sophonneary Prak, Kroeun Hou, Tze Lin Chai, Ame Stormer, Sokhoing Ly, Robyn Devenish, Christian Oberkanins, Helene Pühringer, Kimberly B Harding, Luz M De-Regil, Klaus Kraemer, Tim J Green, Crystal D Karakochuk, Mikaela K Barker, Kyly C Whitfield, Susan I Barr, Suzanne M Vercauteren, Angela M Devlin, Jennifer A Hutcheon, Lisa A Houghton, Sophonneary Prak, Kroeun Hou, Tze Lin Chai, Ame Stormer, Sokhoing Ly, Robyn Devenish, Christian Oberkanins, Helene Pühringer, Kimberly B Harding, Luz M De-Regil, Klaus Kraemer, Tim J Green
Abstract
Background: Despite a high prevalence of anemia among nonpregnant Cambodian women, current reports suggest that iron deficiency (ID) prevalence is low. If true, iron supplementation will not be an effective anemia reduction strategy.Objective: We measured the effect of daily oral iron with or without multiple micronutrients (MMNs) on hemoglobin concentration in nonpregnant Cambodian women screened as anemic.Design: In this 2 × 2 factorial, double-blind, randomized trial, nonpregnant women (aged 18-45 y) with hemoglobin concentrations ≤117 g/L (capillary blood) were recruited from 26 villages in Kampong Chhnang province and randomly assigned to receive 12 wk of iron (60 mg; Fe group), MMNs (14 other micronutrients; MMN group), iron plus MMNs (Fe+MMN group), or placebo capsules. A 2 × 2 factorial intention-to-treat analysis with the use of a generalized mixed-effects model was used to assess the effects of iron and MMNs and the interaction between these factors. Results: In July 2015, 809 women were recruited and 760 (94%) completed the trial. Baseline anemia prevalence was 58% (venous blood). Mean (95% CI) hemoglobin concentrations at 12 wk in the Fe, MMN, Fe+MMN, and placebo groups were 121 (120, 121), 116 (116, 117), 123 (122, 123), and 116 (116, 117) g/L, with no iron × MMN interaction (P = 0.66). Mean (95% CI) increases in hemoglobin were 5.6 g/L (3.8, 7.4 g/L) (P < 0.001) among women who received iron (n = 407) and 1.2 g/L (-0.6, 3.0 g/L) (P = 0.18) among women who received MMNs (n = 407). The predicted proportions (95% CIs) of women with a hemoglobin response (≥10 g/L at 12 wk) were 19% (14%, 24%), 9% (5%, 12%), 30% (24%, 35%), and 5% (2%, 9%) in the Fe, MMN, Fe+MMN, and placebo groups, respectively.Conclusions: Daily iron supplementation for 12 wk increased hemoglobin in nonpregnant Cambodian women; however, MMNs did not confer additional significant benefit. Overall, ∼24% of women who received iron responded after 12 wk; even fewer would be likely to respond in the wider population. This trial was registered at clinicaltrials.gov as NCT02481375.
Keywords: Cambodia; anemia; hemoglobin; iron; micronutrient; supplementation; women.
© 2017 American Society for Nutrition.
Source: PubMed